Project Grant R03DA060344

Award Date 5/1/25
Completion Date 4/30/27
Dollars Obligated $79K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), funded under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the "need-state hypothesis" in cocaine addiction. The $685,856 award to Pennsylvania State University, specifically the Penn State Milton S. Hershey Medical Center, aims to use an animal model to identify early indicators of addiction vulnerability and test whether a glucagon-like peptide-1 (GLP-1)...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $166,512 to The Trustees of Columbia University in the City of New York to conduct a longitudinal study on cognitive, behavioral, and brain-based markers of self-regulation as predictors of cannabis and alcohol co-use in adolescence. The key objectives of this 5-year study are to: 1) examine how impairments in executive functioning and high...
This Project Grant award, with a total funding amount of $368,315, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will support the design and testing of a translational rat model of the neonatal intensive care unit (NICU) experience and its impact on substance use disorder (SUD) vulnerability. Specifically, the grant will fund the development of a novel rat model combining early life pain, resource scarcity,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $234,000.00 to Oregon Health & Science University (OHSU) to conduct research on rapid protein translation in nucleus accumbens neurons in response to a cocaine-associated cue. The key objectives are to: 1) Use translating ribosome affinity purification and RNA sequencing (TRAP-seq) to identify mRNAs that are actively translating in...
This federal Project Grant award, totaling $346,911, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award, valid from August 15, 2024 to July 31, 2026, will support a cross-species study to identify neurocognitive, genetic, and socioenvironmental risk factors for substance use disorders (SUDs). The key objectives of the project are to: 1) determine how early life environment influences neurocognitive development...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $249,236 to Duke University to study the chromatin regulation of brain-derived neurotrophic factor (BDNF) in cocaine craving and relapse. The project aims to use innovative molecular genetic methods to define the chromatin architecture changes in dopamine neurons that accompany persistent alterations in gene expression, specifically focused on...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on investigating a specialized serotonergic-septohippocampal circuit that may influence the vulnerability for relapse in substance use disorders. The $254,250 award, spanning from July 2024 to June 2026, will support the delineation of the intrinsic properties and transmission interactions of a novel neuronal cell type (LSI-R2P) that is modulated...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the effects of HIV infection on stress-induced cocaine relapse in male and female mice. The $454,500 grant, awarded to Drexel University, will support research with the following key objectives: Determine the impact of EcoHIV inoculation on stress-induced corticosterone levels and astrocytic glucocorticoid receptor...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $656,121 to The Johns Hopkins University to investigate the impact of adolescent cannabis use on prefrontal cortex maturation and cognitive function. The key objectives of the research are to: 1) Identify the molecular and morphological changes in microglia induced by adolescent THC exposure via cannabinoid receptor type 1 (CNR1) signaling;...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $295,325 to Epivario Inc. to develop a novel small molecule inhibitor of the metabolic enzyme ACSS2 as a potential treatment for cocaine use disorder (CUD). The key objectives are to assess the pharmacological properties, including selectivity, efficacy on epigenetic regulation, and pharmacokinetics, of Epivario's lead ACSS2 inhibitor...

IMPACT OF COCAINE-ASSOCIATED CUES AND CONTEXTS ON ADOLESCENT RELAPSE - PROJECT SUMMARY ADOLESCENCE IS A CRITICAL JUNCTURE WHEN INITIATION OF DRUG USE INTERSECTS WITH PROFOUND DEVELOPMENTAL AND STRUCTURAL CHANGES IN THE BRAIN. IT IS WELL KNOWN THAT ADOLESCENT DRUG USE INCREASES THE RISK TO DEVELOP SUBSTANCE USE DISORDERS (SUDS) LATER IN LIFE, BUT THE MECHANISMS THAT CONFER THIS VULNERABILITY ARE NOT UNDERSTOOD. SUDS ARE DEFINED BY CYCLES OF USE, ABSTINENCE, AND RELAPSE. INTENSE CRAVING DURING DRUG-FREE PERIODS IS OFTEN TRIGGERED BY CUES AND ENVIRONMENTAL CONTEXTS ASSOCIATED WITH PREVIOUS USE. IN ADOLESCENTS, THERE IS A GAP IN KNOWLEDGE ON THE FUNDAMENTAL BRAIN AND BEHAVIORAL CHANGES OCCURRING DURING ABSTINENCE. WE ESTABLISHED AN ABBREVIATED MODEL OF COC-SA (ABRV COC-SA) THAT PERMITS US TO EXAMINE RELAPSE DURING ADOLESCENCE. WE FIND THAT ADOLESCENT RATS SHOW INCUBATION OF CRAVING IN A PREVIOUS COCAINE-PAIRED CONTEXT, WHEREAS ADULTS DO NOT. OUR DATA SUGGEST THAT ADOLESCENT RATS ARE MORE SENSITIVE TO COCAINE-RELATED CONTEXTUAL STIMULI COMPARED TO ADULTS, WHICH CONTRASTS WITH THEIR REDUCED REACTIVITY TO COCAINE-PAIRED CUES (I.E. CONDITIONED STIMULI- CS). OUR OVERALL GOAL IS TO PROVIDE A COMPREHENSIVE UNDERSTANDING OF THE DISTINCT COCAINE-ASSOCIATED STIMULI THAT TRIGGER CRAVING AND RELAPSE IN ADOLESCENT RATS. AIM 1 WILL TEST THE WORKING HYPOTHESIS THAT CONTEXT-INDUCED INCUBATION OF COCAINE SEEKING IN ADOLESCENT RATS RESULTS FROM EARLIER ONSET OF INCUBATION COMPARED TO ADULTS. ADOLESCENT AND ADULT MALE AND FEMALE RATS WILL RECEIVE ABRV COC-SA IN AN CONTEXT WITH DIFFUSE BACKGROUND STIMULI, LEVER EXTINCTION IN A SECOND CONTEXT (NO REWARD). AFTER 1, 15 OR 30 DAYS OF ABSTINENCE, RELAPSE TESTS WILL OCCUR IN THE PREVIOUS COCAINE CONTEXT. AIM 2 WILL TEST THE WORKING HYPOTHESIS THAT INCUBATION OF COCAINE SEEKING IN ADOLESCENT RATS IS SPECIFIC TO CONTEXTUAL STIMULI RATHER THAN COCAINE-PAIRED CSS. ADOLESCENT AND ADULT MALE AND FEMALE RATS WILL RECEIVE ABRV COC-SA, WITH COCAINE INFUSION PAIRED WITH CS, LEVER EXTINCTION WILL OCCUR IN THE SAME CONTEXT (NO REWARD, NO CS). AFTER 1, 15 OR 30 DAYS OF ABSTINENCE, RELAPSE TESTS WILL OCCUR WITH RESPONSE-CONTINGENT PRESENTATION OF COCAINE-PAIRED CS. OUR PROPOSAL WILL ESTABLISH FOUNDATIONAL KNOWLEDGE ABOUT THE UNIQUE TRIGGERS OF CRAVING IN AN ADOLESCENT RAT MODEL. THIS KNOWLEDGE IS CRITICAL TO INFORM IMPROVED BEHAVIORAL INTERVENTIONS TARGETED TO REDUCE RELAPSE IN HUMAN ADOLESCENTS.

Posted 4/21/25, 12:00 AM